Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Revised VMR reforms published following feedback
The changes to the reforms have been welcomed by the BVA.
VMD sets out amended plans to update regulations.

The Veterinary Medicines Directorate (VMD) has published revised plans to amend the Veterinary Medicines Regulations 2013 (VMR), dropping somes of its initial proposals and changing others.

The changes come after an eight-week public consultation last year received responses from 188 individuals and organisations. Although many of the responses were supportive, the VMD has responded to concerns raised by stakeholders over some of the plans.

Planned changes which have been dropped include:
    •    Only allowing veterinary prescription-only medicines to be advertised to animal keepers if they are immunological medicines
    •    Changing the classification for new immunological veterinary medicines so they can only be prescribed by veterinary surgeons
    •    Changing prescribing requirements for veterinary surgeons to include ‘clinical examination or other proper assessment’ instead of ‘clinical assessment’.

There have also been amendments made to other proposals, including the proposed changes to labelling requirements for veterinary medicines.

The VMR, which regulate the marketing, manufacture, distribution, possession and administration of veterinary medicines and medicated feed, have previously only been slightly altered since they were introduced in October 2013.

Abi Seager, VMD chief executive officer, said: “We are grateful to everyone who took the time to provide considered responses to our consultation.

“We are pleased with the support for the proposed changes. Where the feedback identified disproportionate impacts on certain businesses or unintended consequences on animal health and welfare, we have acted and amended our proposals.

“We look forward to continuing engagement with all our stakeholders and support[ing] them through the implementation of the upcoming changes.”

The newly published plans have been welcomed by the British Veterinary Association (BVA).

Anna Judson, BVA president, said: “We’re pleased to see that the government has listened to the concerns we raised in our consultation response last year. These are reflected in amendments including the appropriate use of the cascade, the prescribing of medicated feed, and a commitment towards better regulation of online pharmacies.

“BVA will take time to carefully review the details of the government’s consultation response and share feedback with [the] government and our members.”

Image © Shutterstock

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.